<?xml version="1.0" encoding="UTF-8"?>
<p>Numerous other treatments, such as immunomodulators, carbamazepineamantadine, steroids, cimetidine, and plasmapheresis have been tested to treat SSPE but their efficacy seems to be case-dependent and need to be confirmed [
 <xref rid="B216-viruses-11-01017" ref-type="bibr">216</xref>,
 <xref rid="B217-viruses-11-01017" ref-type="bibr">217</xref>]. In addition, several alternative inhibitors such as antisense molecules, adenosine, and guanosine nucleosides, including ring-expanded “fat” nucleoside analogues, brassinosteroids, coumarins, modulators of cholesterol synthesis, and a variety of natural products have been investigated on MeV-infected patients. All these inhibitors showed relative efficacy or toxicity in vitro and in vivo and remain to be improved [
 <xref rid="B236-viruses-11-01017" ref-type="bibr">236</xref>]. Among patients who received two doses of vaccine after initial infection some developed SSPE suggesting that the vaccine may not act as a therapeutic cure and prevent from encephalitis in this particular case [
 <xref rid="B237-viruses-11-01017" ref-type="bibr">237</xref>].
</p>
